Therapy Development Director, Coronary Therapies EMEA

Work mode: Remote in Country. Onsite Location(s): Hemel Hempstead, HRT, GB

Diversity - Innovation - Caring - Global Collaboration - Winning Spirit - High Performance

Boston Scientific will give you the opportunity to harness all that’s within you by working in teams of diverse and high-performing employees, tackling some of the most important health industry challenges.

Therapy Development Director, Coronary Therapies EMEA

This role can be based in Italy, Spain, UK, France, Germany.

Role Overview: As Therapy Development Director, Coronary Therapies EMEA, you will play a pivotal role in shaping the future of Boston Scientific’s leadership in interventional cardiology.

You will spearhead the Modern PCI strategy across EMEA, driving double-digit growth, accelerating therapy adoption, and positioning the company as the category leader. This highly visible role sits on the EMEA Coronary Therapies Leadership Team and works in close partnership with global business leaders.

You will have direct responsibility for defining and executing commercial strategies for our Modern PCI portfolio, future portfolio and therapy expansion (Renal Denervation & Interventional Heart Failure).

Key Responsibilities:

• Define and execute regional commercial strategies to accelerate growth and market leadership in Modern PCI.
• Own commercial outcomes with accountability for top-line revenue, therapy adoption, and category share gains.
• Partner closely with local and regional leadership team, cluster directors and business unit managers on planning, performance reviews during QBRs, and field support activities.
• Design and implement regional strategies that reflect market dynamics, leveraging field insights, competitive intelligence, and customer feedback.
• Drive go-to-market evolution and sales organization transformation, expansion into new therapies and in strong collaboration with local commercial leaders and the commercial excellence team.
• Accelerate therapy adoption and optimize revenue performance across the Coronary Therapies portfolio.
• Act as a key voice from EMEA into global franchise strategy forums.

Market Development & Clinical Engagement: Build and maintain strategic relationships with Key Opinion Leaders (KOLs) and clinical influencers. Shape clinical strategy and identify centers and advisors for studies and therapy validation.

Team & People Development: Lead and inspire a high-performing therapy development team across EMEA. Foster a culture of innovation, accountability, and clinical excellence.

Required Qualifications:

• Proven sales leadership experience with extensive exposure to interventional cardiology or related cardiovascular therapies.
• Demonstrated success in strategic sales, market development, or business unit leadership roles.
• Track record of cross-border leadership, new technology launches, and therapy adoption acceleration.
• Strong strategic thinker with analytical, problem-solving, and execution capabilities.
• Exceptional communicator with proven ability to influence senior stakeholders, physicians, and commercial teams.
• Fluent in English; additional proficiency in French, German, Italian, or Spanish is highly desirable.
• Willingness and ability to travel extensively across EMEA.
• Direct experience with PCI and emerging cardiovascular therapies (e.g., Interventional HF, Renal Denervation).
• Bachelor's degree required; Master's degree (MSc) in a technical, clinical, or business-related discipline is preferred.

Boston Scientific is committed to solving the challenges that matter most – united by a deep caring for human life. Our mission to advance science for life is about transforming lives through innovative medical solutions.